Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results

View All

Jan 13, 2020 • 7:30 AM EST

Rigel Pharmaceuticals Provides Business Update

Jan 9, 2020 • 7:30 AM EST

Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference

Dec 17, 2019 • 5:00 PM EST

Rigel Announces Chief Commercial Officer Transition

January 2020

View Presentation

Fourth Quarter and Year End 2019 Financial Results Conference Call

View Event Add to Calendar View All

Q3 2019

Quarter Ended Sep 30, 2019

Earnings Release

PDF HTML

Audio

Earnings Webcast

Earnings Presentation

PDF

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2018

Investor Contact Information

Company

Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080